Experience

China Renaissance 华兴资本

• China
• Investment Banking
• 200 - 300 Employee

• Vice President

  • Aug 2017 - Present

  • Responsible for Pharmaceutical and Molecular Diagnosis industry mapping, project sourcing, pitching and engagement • Assisting execution team to complete private placement transactions by preparing company business plan, valuation materials, competition landscape analysis, as well as participating negotiations of term sheet, SPA and SHA• Completed projects▪ Innocare: innovative small molecular drug R&D▪ CMAB: biologics CDMO▪ I-MAB: innovative biologics drug R&D• Ongoing projects▪ TransThera: innovative small molecular drug R&D▪ Genova: biosimilar drug development and manufactory



Mefund Capital

• Director

  • Jul 2016 - Jul 2017

  Responsible for project sourcing and investment in pharmaceutical, diagnosis and medical device areas• Completed projects▪ AmcareLab: diagnosis and clinical genetic consulting for genetic diseases and cancero Project leader for A round investment▪ SinoSurgical: instruments and consumables R&D for minimally invasive surgery and interventional tumor therapyo Project team member for A round investment Responsible for project sourcing and investment in pharmaceutical, diagnosis and medical device areas• Completed projects▪ AmcareLab: diagnosis and clinical genetic consulting for genetic diseases and cancero Project leader for A round investment▪ SinoSurgical: instruments and consumables R&D for minimally invasive surgery and interventional tumor therapyo Project team member for A round investment



HD Biosciences Co., Ltd.

• Associate Director

  • Oct 2010 - Jul 2016

  • Program leader of the exploratory biology program in collaboration with multinational pharmaceutical companies (Pfizer, Lilly, JNJ, Sanofi, etc.) for new drug R&D▪ Novel target identification and validation for cancer treatmento Led more than 20 target validation projects covering multiple aspects of cancer biology including oncogenic signaling pathways, cancer metabolism and immuno-oncologyo Led more than 10 projects in deciphering new drug MOA (mechanism of action)• Team leader of the biological assay development and screening team for hit identification, lead optimization and drug candidate selection



Pharmaron

• China
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Scientist

  • Dec 2009 - Sep 2010

  • Building up protein expression and structure analysis capability • Building up protein expression and structure analysis capability